GO:0035767 endothelial cell chemotaxis: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035767 endothelial cell chemotaxis is the directed movement of an endothelial cell along a chemical concentration gradient, either toward higher (positive) or lower (negative) concentration.
• The process is central to angiogenesis, vascular repair, and immune cell recruitment, and is driven by cytoskeletal reorganization and cell-cell interactions.
• Key molecular regulators include CMG2, ABHD1, KRT1/KRT2, STING, and calcium signaling components.
• Dysregulated endothelial cell chemotaxis contributes to diabetic retinopathy, abdominal aortic aneurysm, atherosclerosis, and acute lung injury.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect causal roles of candidate genes in endothelial chemotaxis.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate endothelial chemotaxis research.
Description
Endothelial cell chemotaxis (GO:0035767) is a fundamental biological process in which endothelial cells migrate directionally in response to a chemical gradient. This directed movement is essential for vascular development, wound healing, and immune surveillance, and its dysregulation underlies numerous pathological conditions including diabetic retinopathy, aneurysm formation, and acute lung injury. Understanding the molecular players that govern endothelial cell chemotaxis is critical for developing targeted therapies. Recent studies have identified key regulators such as CMG2, which mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis, and ABHD1, which facilitates intermediate filament-mediated chemotaxis in diabetic retinopathy. Moreover, cell-cell interactions and cytoskeletal organization are known to modulate collective endothelial cell chemotaxis. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0035767, covering its definition, mechanisms, key genes, disease relevance, and state-of-the-art research methods including CRISPR-based models.
endothelial cell chemotaxis At A Glance
| GO ID | GO:0035767 |
|---|---|
| GO term | endothelial cell chemotaxis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of endothelial cells along a chemical gradient, essential for angiogenesis, vascular repair, and immune cell recruitment |
| Related processes | Angiogenesis, cell migration, cytoskeletal reorganization, calcium signaling |
| Key regulators | CMG2, ABHD1, KRT1, KRT2, STING, calcium signaling components |
| Disease relevance | Diabetic retinopathy, abdominal aortic aneurysm, atherosclerosis, acute lung injury |
What Is GO:0035767?
According to the Gene Ontology, GO:0035767 endothelial cell chemotaxis is defined as the directed movement of an endothelial cell guided by a specific chemical concentration gradient. The movement may be toward a higher concentration of the chemical (positive chemotaxis) or toward a lower concentration (negative chemotaxis). This process is a specialized form of cell chemotaxis that is restricted to endothelial cells and plays a critical role in vascular biology.
Why Is endothelial cell chemotaxis Important in Cell Biology?
Endothelial cell chemotaxis is indispensable for both physiological and pathological processes. During development and tissue repair, it drives angiogenesis and vascular remodeling. In inflammation, it facilitates immune cell recruitment by guiding endothelial cells to sites of injury. Dysregulation of this process is a hallmark of diabetic retinopathy, where ABHD1-mediated chemotaxis contributes to disease progression, and of abdominal aortic aneurysm, where vitamin D receptor activation reduces angiotensin-II-induced aneurysm formation. Additionally, STING inhibition ameliorates LPS-induced acute lung injury by preventing endothelial cell-mediated immune cell chemotaxis and adhesion. Thus, understanding the molecular mechanisms of endothelial cell chemotaxis is crucial for identifying therapeutic targets.
• Critical for angiogenesis and vascular development.
• Mediates immune cell recruitment during inflammation.
• Dysregulated in diabetic retinopathy via ABHD1 and intermediate filaments.
• Involved in abdominal aortic aneurysm pathogenesis, modulated by vitamin D receptor.
• Contributes to atherosclerosis and endothelial injury, regulated by NF-kappa-B pathway.
• Plays a role in acute lung injury through STING-mediated chemotaxis.
• Requires calcium signaling for barrier function and inflammation.
• Cell-cell interactions and cytoskeletal organization are essential for collective chemotaxis.
• Target for procyanidin B2 and other anti-inflammatory compounds.
• Provides a model for studying directed cell migration and gradient sensing.
What Happens During endothelial cell chemotaxis?
Gradient Sensing and Receptor Activation
In simple terms: The cell detects a chemical signal and gets ready to move.
Endothelial cells sense chemical gradients through surface receptors, which upon activation trigger intracellular signaling cascades. Calcium signaling is a key mediator during barrier function and inflammation, influencing chemotactic responses. Growth factor receptors, such as those activated by CMG2, initiate signaling that leads to directed migration.
Cytoskeletal Reorganization and Cell Polarization
In simple terms: The cell's skeleton rearranges to push it forward.
Upon gradient sensing, the endothelial cell polarizes, with actin and intermediate filament networks reorganizing to form protrusive structures at the leading edge. ABHD1 facilitates intermediate filament-mediated chemotaxis by regulating KRT1 and KRT2, which are essential for cytoskeletal dynamics during migration. Cell-cell interactions further mediate cytoskeleton organization and collective endothelial cell chemotaxis.
Adhesion and Traction Forces
In simple terms: The cell grips the surface and pulls itself along.
Integrins and other adhesion molecules mediate attachment to the extracellular matrix, generating traction forces that propel the cell forward. This step is tightly linked to chemotactic signaling and is modulated by inflammatory pathways, as seen in oxidized LDL-induced endothelial injury where NF-kappa-B inhibition reduces monocyte chemotaxis.
Directed Migration and Collective Movement
In simple terms: The cell moves in a coordinated way, sometimes as a group.
Endothelial cells migrate directionally along the gradient, often as collective sheets during angiogenesis. Collective chemotaxis requires cell-cell communication and coordinated cytoskeletal activity. This process is critical for capillary morphogenesis, where CMG2 regulates growth factor-induced angiogenesis by controlling endothelial cell chemotaxis.
Resolution and Integration with Immune Responses
In simple terms: The movement stops or integrates with immune cell recruitment.
Chemotaxis is resolved once the gradient dissipates or the target is reached. Endothelial cells can also present antigens via MHC II to recruit and activate T-cells, linking chemotaxis to adaptive immunity. STING signaling modulates endothelial cell-mediated immune cell chemotaxis and adhesion, as shown in LPS-induced acute lung injury.
Key Genes Involved in GO:0035767 endothelial cell chemotaxis
The following genes and proteins have been experimentally implicated in endothelial cell chemotaxis, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CMG2 | Mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis | Knockout reduces capillary morphogenesis; target for anti-angiogenic therapy |
| ABHD1 | Facilitates intermediate filament-mediated chemotaxis by regulating KRT1 and KRT2 | Knockdown impairs chemotaxis in diabetic retinopathy models |
| KRT1 | Intermediate filament component involved in cytoskeletal reorganization during chemotaxis | Regulated by ABHD1; potential target in diabetic retinopathy |
| KRT2 | Intermediate filament component involved in cytoskeletal reorganization during chemotaxis | Regulated by ABHD1; potential target in diabetic retinopathy |
| STING | Modulates endothelial cell-mediated immune cell chemotaxis and adhesion | Inhibition ameliorates LPS-induced acute lung injury |
| VDR | Vitamin D receptor; activation reduces angiotensin-II-induced aneurysm | Knockout mice show increased aneurysm; VDR activation is protective |
| NF-kappa-B | Inflammatory pathway regulating monocyte chemotaxis and endothelial injury | Inhibition by procyanidin B2 reduces oxidized LDL-induced injury |
| Calcium signaling components | Mediate barrier function and inflammation | Modulate chemotactic responses; targets for barrier protection |
| MHC II | Antigen presentation to T-cells | Immunomodulatory endothelial cells contribute to T-cell recruitment |
| Actin cytoskeleton regulators | Control cell polarization and protrusion | Essential for collective chemotaxis |
| Integrins | Mediate adhesion and traction forces | Required for directed migration; potential therapeutic targets |
| Growth factor receptors | Initiate signaling cascades for chemotaxis | Targets for angiogenesis inhibition |
| Chemokine receptors | Sense chemical gradients | Mediate immune cell recruitment |
| Adhesion molecules | Facilitate cell-cell and cell-matrix interactions | Modulate collective chemotaxis |
| Inflammatory cytokines | Regulate chemotaxis in pathological conditions | Targets for anti-inflammatory therapy |
| Oxidized LDL | Induces endothelial injury and monocyte chemotaxis | Model for atherosclerosis research |
| Angiotensin II | Induces aneurysm formation via endothelial dysfunction | Model for abdominal aortic aneurysm |
| LPS | Triggers STING-mediated chemotaxis in acute lung injury | Model for inflammation research |
How Is endothelial cell chemotaxis Regulated?
Endothelial cell chemotaxis is regulated by multiple signaling pathways. Calcium signaling modulates barrier function and inflammation, influencing chemotactic responses. The NF-kappa-B pathway is activated by oxidized LDL and promotes monocyte chemotaxis; inhibition by procyanidin B2 reduces this effect. Vitamin D receptor activation reduces angiotensin-II-induced abdominal aortic aneurysm, partly by modulating endothelial chemotaxis. STING signaling is a key regulator in LPS-induced acute lung injury, where its inhibition prevents endothelial cell-mediated immune cell chemotaxis. Additionally, cell-cell interactions and cytoskeletal organization are critical for collective chemotaxis.
endothelial cell chemotaxis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABHD1 | Diabetic retinopathy | Knockout or knockdown in endothelial cells; chemotaxis assays |
| VDR | Abdominal aortic aneurysm | Knockout mice; angiotensin-II infusion model |
| STING | Acute lung injury | Inhibitor treatment in LPS-induced ALI mouse model |
| NF-kappa-B | Atherosclerosis | Oxidized LDL-treated HUVECs; procyanidin B2 intervention |
| CMG2 | Angiogenesis disorders | Knockout mice; growth factor-induced angiogenesis assays |
Diabetic Retinopathy
ABHD1 facilitates intermediate filament-mediated endothelial cell chemotaxis by regulating KRT1 and KRT2, contributing to the pathogenesis of diabetic retinopathy. Knockdown of ABHD1 impairs chemotaxis, suggesting a potential therapeutic target.
Abdominal Aortic Aneurysm
Vitamin D receptor activation reduces angiotensin-II-induced dissecting abdominal aortic aneurysm in apolipoprotein E-knockout mice, partly by modulating endothelial cell chemotaxis and vascular remodeling.
Acute Lung Injury
STING inhibitor ameliorates LPS-induced acute lung injury by preventing vascular endothelial cell-mediated immune cell chemotaxis and adhesion, highlighting the role of STING in endothelial chemotaxis during inflammation.
Atherosclerosis
Procyanidin B2 alleviates oxidized low-density lipoprotein-induced cell injury, inflammation, monocyte chemotaxis, and oxidative stress by inhibiting the NF-kappa-B pathway in human umbilical vein endothelial cells, linking endothelial chemotaxis to atherosclerosis.
From endothelial cell chemotaxis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate endothelial cell chemotaxis? | CRISPR knockout in endothelial cells followed by chemotaxis assay |
| Does a specific point mutation in gene X affect chemotaxis? | CRISPR point mutation knock-in in endothelial cells |
| Does overexpression of gene X enhance chemotaxis? | CRISPR overexpression (CRISPRa) or lentiviral overexpression |
| Does tagging gene X with a fluorescent marker affect its localization during chemotaxis? | CRISPR knock-in of fluorescent tag |
| What is the role of gene X in collective chemotaxis? | CRISPR knockout in co-culture models |
| Can gene X be targeted to treat diabetic retinopathy? | CRISPR knockout in mouse models of diabetic retinopathy |
How to Study the endothelial cell chemotaxis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell assay | Directed cell migration | Quantify chemotaxis after CRISPR knockout |
| Microfluidic gradient assay | Chemotaxis in controlled gradients | Study gradient sensing and collective migration |
| Live-cell imaging | Dynamic cytoskeletal changes | Visualize polarization and protrusion |
| Calcium imaging | Intracellular calcium levels | Assess calcium signaling during chemotaxis |
| RNA-seq | Gene expression changes | Identify regulators of chemotaxis |
| Proteomics | Protein abundance and modifications | Discover signaling pathways |
| Immunofluorescence | Protein localization | Study intermediate filament reorganization |
| CRISPR screening | Genome-wide identification of regulators | Discover novel chemotaxis genes |
Chemotaxis Assays
Transwell and microfluidic gradient assays are standard for measuring endothelial cell chemotaxis. These methods quantify directed migration in response to chemical gradients and are used to assess gene function after CRISPR editing.
Live-Cell Imaging and Cytoskeletal Analysis
Live-cell imaging combined with fluorescently tagged cytoskeletal proteins allows visualization of dynamic changes during chemotaxis. This approach has been used to study cell-cell interactions and cytoskeleton organization in collective endothelial cell chemotaxis.
Calcium Signaling Measurements
Calcium imaging and signaling assays are employed to study the role of calcium in endothelial barrier function and inflammation, which are linked to chemotaxis.
Transcriptomics and Proteomics
RNA-seq and proteomics can identify genes and proteins differentially expressed during chemotaxis. For example, ABHD1 regulation of KRT1 and KRT2 was discovered through such approaches.
How CRISPR Can Be Used to Study GO:0035767 endothelial cell chemotaxis
Knockout
CRISPR knockout is used to completely ablate candidate genes to determine their necessity in endothelial cell chemotaxis. For example, knockout of CMG2 impairs growth factor-induced angiogenesis and chemotaxis, and knockout of ABHD1 reduces intermediate filament-mediated chemotaxis.
Point Mutation
CRISPR point mutation knock-in allows introduction of specific amino acid substitutions to study structure-function relationships. This is useful for dissecting signaling domains in receptors or kinases involved in chemotaxis.
Knock-in
CRISPR knock-in of fluorescent tags or reporter genes enables real-time visualization of protein localization and dynamics during chemotaxis. Tagging cytoskeletal components can reveal their reorganization during directed migration.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression is used to test gain-of-function effects. Overexpression of procyanidin B2 targets or NF-kappa-B inhibitors can suppress chemotaxis, as shown in oxidized LDL-treated endothelial cells.
How EDITGENE Supports endothelial cell chemotaxis Research
Researchers studying endothelial cell chemotaxis-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. This requires precise genetic manipulation, which is where EDITGENE's CRISPR services can accelerate discovery.
Contact EDITGENE today to design your custom CRISPR model for endothelial cell chemotaxis research.
Frequently Asked Questions About endothelial cell chemotaxis
What is endothelial cell chemotaxis?
Endothelial cell chemotaxis (GO:0035767) is the directed movement of an endothelial cell guided by a specific chemical concentration gradient, either toward higher (positive) or lower (negative) concentration.
What genes are involved in endothelial cell chemotaxis?
Key genes include CMG2, ABHD1, KRT1, KRT2, STING, VDR, and NF-kappa-B, among others.
How is endothelial cell chemotaxis regulated?
It is regulated by calcium signaling, NF-kappa-B pathway, vitamin D receptor activation, and STING signaling, as well as cell-cell interactions and cytoskeletal reorganization.
What diseases are associated with endothelial cell chemotaxis?
Diabetic retinopathy, abdominal aortic aneurysm, acute lung injury, and atherosclerosis are linked to dysregulated endothelial cell chemotaxis.
What methods are used to study endothelial cell chemotaxis?
Transwell assays, microfluidic gradients, live-cell imaging, calcium imaging, RNA-seq, proteomics, and CRISPR screening are commonly used.
How can CRISPR be used to study endothelial cell chemotaxis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise genetic manipulation to test gene function in chemotaxis.
What is the role of CMG2 in endothelial cell chemotaxis?
CMG2 mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis, and its knockout impairs capillary morphogenesis.
How does ABHD1 affect endothelial cell chemotaxis?
ABHD1 facilitates intermediate filament-mediated chemotaxis by regulating KRT1 and KRT2, contributing to diabetic retinopathy.
What is the link between STING and endothelial cell chemotaxis?
STING inhibition ameliorates LPS-induced acute lung injury by preventing vascular endothelial cell-mediated immune cell chemotaxis and adhesion.
Can endothelial cell chemotaxis be targeted therapeutically?
Yes, targeting pathways such as NF-kappa-B, VDR, and STING shows promise in preclinical models of atherosclerosis, aneurysm, and acute lung injury.
Conclusion
Endothelial cell chemotaxis (GO:0035767) is a vital biological process with broad implications in vascular biology, immunology, and disease. The integration of QuickGO definitions with verified PubMed literature reveals a complex network of genes and signaling pathways, including CMG2, ABHD1, STING, and NF-kappa-B, that orchestrate directed endothelial cell migration. Dysregulation of this process contributes to diabetic retinopathy, abdominal aortic aneurysm, acute lung injury, and atherosclerosis. Advances in CRISPR-based models and screening technologies are accelerating the discovery of novel regulators and therapeutic targets. EDITGENE's comprehensive CRISPR services empower researchers to dissect these mechanisms with precision and speed.
References
- 1. Wu B et al.. 2022. STING inhibitor ameliorates LPS-induced ALI by preventing vascular endothelial cells-mediated immune cells chemotaxis and adhesion.. Acta Pharmacol Sin 43(8):2055-2066 PMID: 34907359
- 2. Shamloo A. 2014. Cell-cell interactions mediate cytoskeleton organization and collective endothelial cell chemotaxis.. Cytoskeleton (Hoboken) 71(9):501-12 PMID: 25053533
- 3. Liu X et al.. 2024. ABHD1 Facilitates Intermediate Filament-Mediated Endothelial Cell Chemotaxis by Regulating KRT1 and KRT2 in Diabetic Retinopathy.. J Diabetes Res 2024:5513165 PMID: 39619568
- 4. Dalal PJ et al.. 2020. Endothelial Cell Calcium Signaling during Barrier Function and Inflammation.. Am J Pathol 190(3):535-542 PMID: 31866349
- 5. Martorell S et al.. 2016. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.. Arterioscler Thromb Vasc Biol 36(8):1587-97 PMID: 27283745
- 6. Yuan L et al.. 2024. Procyanidin B2 alleviates oxidized low-density lipoprotein-induced cell injury, inflammation, monocyte chemotaxis, and oxidative stress by inhibiting the nuclear factor kappa-B pathway in human umbilical vein endothelial cells.. BMC Cardiovasc Disord 24(1):231 PMID: 38679696
- 7. Cryan LM et al.. 2022. Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis.. Angiogenesis 25(3):397-410 PMID: 35212873
- 8. Cartura M et al.. 2026. Immunomodulatory endothelial cells contribute to T-cell recruitment and activation via antigen presentation on MHC II.. Cardiovasc Res 122(12):1672-1687 PMID: 42366791
